Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +3.11% |
|
+12.09% | -17.74% |
06-24 | Akebia Therapeutics Names Erik Ostrowski CFO, CBO | MT |
06-24 | Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.74% | 214M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- HC Wainwright Upgrades Akebia Therapeutics to Buy From Neutral